News
Neurodegenerative diseases like Parkinson’s and Alzheimer’s affect millions of people and are becoming more common as the ...
Aging is the primary risk factor for neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis ...
Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key ...
18h
Woman's World on MSNEarly ALS Symptoms in Women: A Harvard Doctor Shares What To Watch ForAmyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been in the headlines lately, owing in large ...
A cancer immunotherapy may slow Parkinson’s disease by blocking the spread of harmful brain proteins, Johns Hopkins researchers found.
Inhibiting an overabundant enzyme saved a key component of a brain signaling pathway that is vital for motor control in a ...
Elizabeth Jonas first got interested in mitochondria by chance. In 1995, she was a postdoctoral researcher at Yale, working ...
Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a ...
Inhibition of LKKR2 may rescue neurons that are dying due to a type of Parkinson’s disease that is caused by a single genetic mutation.
A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.
The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.
Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results